![](/img/cover-not-exists.png)
Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)
Paul M Ridker, Tom Thuren, Andrew Zalewski, Peter LibbyVolume:
162
Year:
2011
Language:
english
Pages:
606
DOI:
10.1016/j.ahj.2011.06.012
File:
PDF, 344 KB
english, 2011